Unknown

Dataset Information

0

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

ABSTRACT: Infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD) has been recently linked to biallelic mutation of the peptidyl-tRNA hydrolase 2 gene PTRH2. Two index patients with IMNEPD in the original report had multiple neurological symptoms such as postnatal microcephaly, intellectual disability, developmental delay, sensorineural deafness, cerebellar atrophy, ataxia, and peripheral neuropathy. In addition, distal muscle weakness and abnormalities of thyroid, pancreas, and liver were found. Here, we report five further IMNEPD patients with a different homozygous PTRH2 mutation, broaden the phenotypic spectrum of the disease and differentiate common symptoms and interindividual variability in IMNEPD associated with a unique mutation. We thereby hope to better define IMNEPD and promote recognition and diagnosis of this novel disease entity.

SUBMITTER: Picker-Minh S 

PROVIDER: S-EPMC4850685 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

Picker-Minh Sylvie S   Mignot Cyril C   Doummar Diane D   Hashem Mais M   Faqeih Eissa E   Josset Patrice P   Dubern Béatrice B   Alkuraya Fowzan S FS   Kraemer Nadine N   Kaindl Angela M AM  

Orphanet journal of rare diseases 20160429 1

Infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD) has been recently linked to biallelic mutation of the peptidyl-tRNA hydrolase 2 gene PTRH2. Two index patients with IMNEPD in the original report had multiple neurological symptoms such as postnatal microcephaly, intellectual disability, developmental delay, sensorineural deafness, cerebellar atrophy, ataxia, and peripheral neuropathy. In addition, distal muscle weakness and abnormalities of thyroid, pancreas, and  ...[more]

Similar Datasets

Unknown Mutations in PTRH2 cause novel infantile-onset multisystem disease with intellectual disability, microcephaly, progressive ataxia, and muscle weakness.
| S-EPMC4284127 | biostudies-literature
Transcriptomics GAA deficiency (Pompe Disease) in infantile-onset patients
2012-06-14 | GSE38680 | GEO
Unknown Enzyme replacement therapy for infantile-onset Pompe disease.
| S-EPMC6486223 | biostudies-literature
Unknown Redefining infantile-onset multisystem phenotypes of coenzyme Q<sub>10</sub>-deficiency in the next-generation sequencing era.
| S-EPMC7791541 | biostudies-literature
Unknown Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.
| S-EPMC4178954 | biostudies-literature
Unknown c.1437G>A intron 9 substitution on acid α-glucosidase gene associated with classic infantile-onset Pompe disease phenotype.
| S-EPMC4499737 | biostudies-literature
Unknown Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.
| S-EPMC6642938 | biostudies-literature
Unknown Infantile onset Pompe disease presenting with non-immune hydrops fetalis.
| S-EPMC6713818 | biostudies-literature
Unknown Rapidly Progressive White Matter Involvement in Early Childhood: The Expanding Phenotype of Infantile Onset Pompe?
| S-EPMC5953890 | biostudies-literature
Unknown KIF5A mutations cause an infantile onset phenotype including severe myoclonus with evidence of mitochondrial dysfunction.
| S-EPMC5042851 | biostudies-literature